Cutaneous lymphoid hyperplasia associated with Leishmania panamensis infection.
Recalcati
Sebastiano
S
Vezzoli
Pamela
P
Girgenti
Valentina
V
Venegoni
Luigia
L
Veraldi
Stefano
S
Berti
Emilio
E
D000284:Administration, Oral; D000368:Aged; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007654:Ketoconazole / Q000008:administration & dosage; D018334:Leishmania guyanensis / Q000302:isolation & purification*; D007897:Leishmaniasis, Mucocutaneous / Q000150:complications / Q000188:drug therapy / Q000469:parasitology* / Q000473:pathology; D010419:Pentamidine / Q000008:administration & dosage; D019310:Pseudolymphoma / Q000188:drug therapy / Q000469:parasitology* / Q000473:pathology; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D010419:Pentamidine; D007654:Ketoconazole